Effect of high- and low-molecular-weight low-substituted hydroxyethyl starch on blood coagulation during acute normovolemic hemodilution in pigs

Anesthesiology

Volumn 105, Issue 6, 2006, Pages 1228-1237

  Thyes, Caroline ^a   Madjdpour, Caveh ^a   Frascarolo, Philippe ^a   Buclin, Thierry ^a   Bürki, Marco ^a   Fisch, Andreas ^b   Burmeister, Marc Alexander ^c   Asmis, Lars ^d   Spahn, Donat R ^a,d  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b B Braun Medical SA   (Switzerland)

^c B Braun Melsungen AG   (Germany)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; ATROPINUM SULF; HETASTARCH; KETAMINE; KETAMINOL; XYLAZINE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DOSE RESPONSE; HEMODILUTION; HEMOSTASIS; HYPERCOAGULABILITY; IN VITRO STUDY; MOLECULAR WEIGHT; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PLASMA VOLUME; PRIORITY JOURNAL; SWINE;

ANIMALS; BLOOD COAGULATION; BLOOD VISCOSITY; HEMODILUTION; HETASTARCH; MOLECULAR WEIGHT; PARTIAL THROMBOPLASTIN TIME; PLASMA SUBSTITUTES; PROTHROMBIN TIME; RESPIRATION, ARTIFICIAL; SWINE; THROMBELASTOGRAPHY;

EID: 33751337497     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/00000542-200612000-00023     Document Type: Article

References (37)

1. Treib J, Baron JF, Grauer MT, Strauss RG: An international view of hydroxyethyl starches. Intensive Care Med 1999; 25:258-68
2. Jungheinrich C, Neff TA: Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet 2005; 44:681-99
3. Vercueil A, Grocott MP, Mythen MG: Physiology, pharmacology, and rationale for colloid administration for the maintenance of effective hemodynamic stability in critically ill patients. Transfus Med Rev 2005; 19:93-109
4. Boldt J: New light on intravascular volume replacement regimens: What did we learn from the past three years? Anesth Analg 2003; 97:1595-604
5. Deusch E, Gamsjager T, Kress HG Kozek-Langenecker SA: Binding of hydroxyethyl starch molecules to the platelet surface. Anesth Analg 2003; 97:680-3
6. Treib J, Haass A, Pindur G: Coagulation disorders caused by hydroxyethyl starch. Thromb Haemost 1997; 78:974-83
7. Jamnicki M, Bombeli T, Seifert B, Zollinger A, Camenzind V, Pasch T, Spahn DR: Low- and medium-molecular-weight hydroxyethyl starches: Comparison of their effect on blood coagulation. ANESTHESIOLOGY 2000; 93:1231-7
8. Jamnicki M, Zollinger A, Seifert B, Popovic D, Pasch T, Spahn DR: Compromised blood coagulation: An in vitro comparison of hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.5 using thrombelastography. Anesth Analg 1998; 87:989-93
9. Felfernig M, Franz A, Braunlich P, Fohringer C Kozek-Langenecker SA: The effects of hydroxyethyl starch solutions on thromboelastography in preoperative male patients. Acta Anaesthesiol Scand 2003; 47:70-3
10. Knutson JE, Deering JA, Hall FW, Nuttall GA, Schroeder DR, White RD, Mullany CJ: Does intraoperative hetastarch administration increase blood loss and transfusion requirements after cardiac surgery? Anesth Analg 2000; 90:801-7
11. Sedrakyan A, Gondek K, Paltiel D, Elefteriades JA: Volume expansion with albumin decreases mortality after coronary artery bypass graft surgery. Chest 2003; 123:1853-7
12. Haynes GR, Havidich JE, Payne KJ: Why the Food and Drug Administration changed the warning label for hetastarch. ANESTHESIOLOGY 2004; 101:560-1
13. de Jonge E, Levi M: Effects of different plasma substitutes on blood coagulation: A comparative review. Crit Care Med 2001; 29:1261-7
14. Entholzner EK, Mielke LL, Calatzis AN, Feyh J, Hipp R, Hargasser SR: Coagulation effects of a recently developed hydroxyethyl starch (HES 130/0.4) compared to hydroxyethyl starches with higher molecular weight. Acta Anaesthesiol Scand 2000; 44:1116-21
15. Madjdpour C, Dettori N, Frascarolo P, Burki M, Boll M, Fisch A, Bombeli T, Spahn DR: Molecular weight of hydroxyethyl starch: Is there an effect on blood coagulation and pharmacokinetics? Br J Anaesth 2005; 94:569-76
16. Hodges KL, Kester WE, Wiederrich DL, Grover JA: Determination of alkoxyl substitution in cellulose ethers by zeisel-gas chromatography. Anal Chem 1979; 51:2172-6
17. Lee YC, Baaske DM, Carter JE: Determination of the molar substitution ratio of hydroxyethyl starches by gas chromatography. Anal Chem 1983; 55:334-8
18. Luddington RJ: Thrombelastography/thromboelastometry. Clin Lab Haematol 2005; 27:81-90
19. Chandler WL: The thrombelastography and the thrombelastograph technique. Semin Thromb Hemost 1995; 21:1-6
20. Camenzind V, Bombeli T, Seifert B, Jamnicki M, Popovic D, Pasch T, Spahn DR: Citrate storage affects Thrombelastograph analysis. ANESTHESIOLOGY 2000; 92:1242-9
21. Whitten CW, Greilich PE: Thromboelastography: Past, present, and future. ANESTHESIOLOGY 2000; 92:1223-5
22. Kozek-Langenecker SA: Effects of hydroxyethyl starch solutions on hemostasis. ANESTHESIOLOGY 2005; 103:654-60
23. Strauss RG, Pennell BJ, Stump DC: A randomized, blinded trial comparing the hemostatic effects of pentastarch versus hetastarch. Transfusion 2002; 42:27-36
24. Langeron O, Doelberg M, Ang ET, Bonnet F, Capdevila X, Coriat P: Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg 2001; 92:855-62
25. Boldt J, Haisch G, Suttner S, Kumle B, Schellhaass A: Effects of a new modified, balanced hydroxyethyl starch preparation (Hextend) on measures of coagulation. Br J Anaesth 2002; 89:722-8
26. Freyburger G, Dubreuil M, Boisseau MR, Janvier G: Rheological properties of commonly used plasma substitutes during preoperative normovolaemic acute haemodilution. Br J Anaesth 1996; 76:519-25
27. Neff TA, Fischler L, Mark M, Stocker R, Reinhart WH: The influence of two different hydroxyethyl starch solutions (6% HES 130/0.4 and 200/0.5) on blood viscosity. Anesth Analg 2005; 100:1773-80
28. Olsen A, Hansen A, Jespersen J, Marckmann P, Bladbjerg E: The pig as a model in blood coagulation and fibrinolysis research. Scand J Lab Anim Sci 1999; 26:214-24
29. McLoughlin TM, Fontana JL, Alving B, Mongan PD, Bunger R: Profound normovolemic hemodilution: Hemostatic effects in patients and in a porcine model. Anesth Analg 1996; 83:459-65
30. Anagnostopoulos PV, Shepard AD, Pipinos II, Raman SB, Chaudhry PA, Mishima T, Morita H, Suzuki G: Analysis of coagulation changes associated with supraceliac aortic crossclamping using thromboelastography. J Surg Res 2001; 98:52-8
31. Via D, Kaufmann C, Anderson D, Stanton K, Rhee P: Effect of hydroxyethyl starch on coagulopathy in a swine model of hemorrhagic shock resuscitation. J Trauma 2001; 50:1076-82
32. Velik-Salchner C, Schnurer C, Fries D, Mussigang PR, Moser PL, Streif W, Kolbitsch C, Lorenz IH: Normal values for thrombelastography (ROTEM®) and selected coagulation parameters in porcine blood. Thromb Res 2006; 117:597-602
33. Munster A, Olsen A, Bladbjerg E: Usefulness of human coagulation and fibrinolysis assays in domestic pigs. Comp Med 2002; 52:39-43
34. Handrigan MT, Burns AR, Donnachie EM, Bowden RA: Hydroxyethyl starch inhibits neutrophil adhesion and transendothelial migration. Shock 2005; 24:434-9
35. Boldt J: Do plasma substitutes have additional properties beyond correcting volume deficits? Shock 2006; 25:103-16
36. Nohe B, Johannes T, Reutershan J, Rothmund A, Haeberle HA, Ploppa A, Schroeder TH, Dieterich HJ: Synthetic colloids attenuate leukocyte-endothelial interactions by inhibition of integrin function. ANESTHESIOLOGY 2005; 103:759-67
37. Lang JD Jr, Figueroa M, Chumley P, Aslan M, Hurt J, Tarpey MM, Alvarez B, Radi R, Freeman BA: Albumin and hydroxyethyl starch modulate oxidative inflammatory injury to vascular endothelium. ANESTHESIOLOGY 2004; 100:51-8